Crucell

Showing 6 posts of 6 posts found.

J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

J&J to acquire Crucell for $2.3 billion

September 17, 2010
Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …

Crucell malaria vaccine starts trials in Africa

May 11, 2010
Research and Development Crucell, malaria

Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …

GSK and Crucell to develop malaria vaccine

April 7, 2010
Sales and Marketing Crucell, GSK, malaria

GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …

J&J buys stake in vaccines firm Crucell

September 29, 2009
Sales and Marketing Crucell, JJ, vaccines

Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …

Crucell linked with new takeover suitors

January 29, 2009
Sales and Marketing Crucell, MA

Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …

The Gateway to Local Adoption Series

Latest content